Publications by authors named "Shirish Gadgeel"

100Publications

Molecular therapeutic targets in non-small cell lung cancer.

Expert Rev Anticancer Ther 2020 Aug 7;20(8):647-661. Epub 2020 Jul 7.

University of Michigan , Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2020.1787156DOI Listing
August 2020

The evolving use of pembrolizumab in combination treatment approaches for non-small cell lung cancer.

Expert Rev Respir Med 2020 02 17;14(2):137-147. Epub 2019 Dec 17.

Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2020.1702526DOI Listing
February 2020

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer.

Lung Cancer (Auckl) 2019 4;10:47-56. Epub 2019 Jun 4.

Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S176391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556538PMC
June 2019

Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2019 05 29;20(3):e362-e368. Epub 2018 Nov 29.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.11.012DOI Listing
May 2019

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.

J Thorac Oncol 2019 01 26;14(1):54-62. Epub 2018 Sep 26.

Department of Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.09.014DOI Listing
January 2019

Immune Checkpoint Inhibitors in the Management of Lung Cancer.

Am Soc Clin Oncol Educ Book 2018 May;38:682-695

From the Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; and the Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_201319DOI Listing
May 2018

Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.

Curr Treat Options Oncol 2018 09 10;19(11):53. Epub 2018 Sep 10.

Department of Internal Medicine, Division of Hematology & Oncology, University of Michigan, 1500 E. Medical Center Drive, 7217 CC, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-018-0568-3
Publisher Site
http://dx.doi.org/10.1007/s11864-018-0568-3DOI Listing
September 2018

New onset myasthenia gravis in a patient with non small cell lung cancer treated with lorlatinib a novel anti-cancer agent.

J Neurol Sci 2018 09 2;392:100-101. Epub 2018 Jul 2.

Department of Neurology, Wayne State University/Detroit Medical Center, United States; Department of Microbiology, Immunology and Biochemistry, Wayne State University, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.06.024DOI Listing
September 2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

N Engl J Med 2018 May 16;378(22):2078-2092. Epub 2018 Apr 16.

From NYU Perlmutter Cancer Center, New York (L.G.); Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria (D.R.-A.), Hospital Universitario Central de Asturias, Oviedo (E.E.), Vall d'Hebron University, Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Fundación Jiménez Díaz (M.D.) and Hospital Universitario Quirón Madrid (B.R.-V.), Madrid - all in Spain; Karmanos Cancer Institute, Detroit (S.G.); Integrated Health and Social Services Centres, Montérégie Centre, Greenfield Park, QC (F.D.A.), and Sunnybrook Health Sciences Centre, Toronto (S.Y.-S.C.) - both in Canada; Southern Medical Day Care Centre, Wollongong, NSW (P.C.), Epworth Healthcare, Richmond, VIC (R.R.J.), Westmead Hospital and University of Sydney, Sydney (R.H.), and Chris O'Brien Lifehouse, Camperdown, NSW (M.B.) - all in Australia; Otto Wagner Hospital, Vienna (M.J.H.); Sanford Health, Sioux Falls, SD (S.F.P.); Thoraxklinik, Heidelberg (H.G.B.), and LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany; Davidoff Cancer Center, Tel Aviv University, Petah Tikva, Israel (N.P.); Ospedale Policlinico San Martino, Genoa (F.G.), University of Turin, Azienda Ospedaliero-Universitaria San Luigi, Orbassano (S.N.), and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - all in Italy; David Geffen School of Medicine at UCLA, Los Angeles (E.B.G.); Kansai Medical University Hospital, Osaka, Japan (T.K.); Moffitt Cancer Center, Tampa, FL (J.E.G.); and Merck, Kenilworth, NJ (J.V., Z.W., J.Y., H.R., M.C.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801005DOI Listing
May 2018

Comparing Treatment Strategies for Stage I Small-cell lung Cancer.

Clin Lung Cancer 2018 09 23;19(5):e559-e565. Epub 2018 Mar 23.

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152878PMC
September 2018

The use of alectinib in the first-line treatment of anaplastic lymphoma kinase-positive non-small-cell lung cancer.

Future Oncol 2018 Aug 14;14(18):1875-1882. Epub 2018 Mar 14.

Department of Internal Medicine, Division of Hematology & Oncology, University of Michigan 1500 E. Medical Center Drive, 7217 CC Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0027DOI Listing
August 2018

Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.

Expert Rev Anticancer Ther 2018 01 26;18(1):63-70. Epub 2017 Nov 26.

c Department of Internal Medicine, Division of Hematology/Oncology , University of Michigan , Ann Arbor , MI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1409624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863145PMC
January 2018

Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

J Thorac Oncol 2018 01 5;13(1):46-53. Epub 2017 Oct 5.

Department of Oncology, Karmanos Cancer Center/Wayne State University School of Medicine, Detroit, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.09.1964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108174PMC
January 2018

The Current Landscape of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer: Emerging Treatment Paradigms and Future Directions.

Target Oncol 2017 Dec;12(6):709-718

Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0526-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000827PMC
December 2017

Retreatment With Osimertinib Following Pneumonitis.

Clin Lung Cancer 2018 01 6;19(1):e53-e55. Epub 2017 Jul 6.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.06.017DOI Listing
January 2018

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2017 08 6;377(9):829-838. Epub 2017 Jun 6.

From Lausanne University Hospital, Lausanne (S.P.), and F. Hoffmann-La Roche, Basel (A.Z., E.M., S. Golding, B.B., J.N.) - both in Switzerland; University of Colorado, Denver (D.R.C.); Massachusetts General Hospital, Boston (A.T.S.); University of Michigan, Ann Arbor (S. Gadgeel); Samsung Medical Center, Sungkyunkwan University School of Medicine (J.S.A.), and Seoul National University Hospital (D.-W.K.) - both in Seoul, South Korea; Chao Family Comprehensive Cancer Center, University of California, Irvine, School of Medicine, Orange (S.-H.I.O.); Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France (M.P.); Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland (R.D.); Catalan Institute of Oncology, Barcelona (R.R.); Roche Innovation Center, New York (P.N.M.); and State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong (T.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1704795DOI Listing
August 2017

Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer.

Am Soc Clin Oncol Educ Book 2017 ;37:630-639

From the Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175188DOI Listing
November 2017

Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer.

Curr Treat Options Oncol 2017 06;18(6):36

Department of Oncology, Karmanos Cancer Institute/Wayne State University, 4100 John R, 4HWCRC, Detroit, MI, 48201, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-017-0479-8
Publisher Site
http://dx.doi.org/10.1007/s11864-017-0479-8DOI Listing
June 2017

Histologic Transformation in NSCLC with PD-1 therapy.

J Thorac Oncol 2017 09 10;12(9):e133-e134. Epub 2017 May 10.

Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.04.026DOI Listing
September 2017

Optimal front-line ALK (anaplastic lymphoma kinase) directed therapy.

Lung Cancer 2017 07 20;109:147-148. Epub 2017 Mar 20.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, 1500 E. Medical Center Dr., Room 7217 CC , Ann Arbor, Michigan, 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.008DOI Listing
July 2017

MET/HGF pathway activation as a paradigm of resistance to targeted therapies.

Ann Transl Med 2017 Jan;5(1)

Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA.

View Article

Download full-text PDF

Source
http://atm.amegroups.com/article/view/13121/13603
Publisher Site
http://dx.doi.org/10.21037/atm.2016.12.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253284PMC
January 2017

Preoperative pulmonary rehabilitation for marginal-function lung cancer patients.

Asian Cardiovasc Thorac Ann 2017 Jan 5;25(1):47-51. Epub 2016 Dec 5.

4 Department of Internal Medicine (Hematology/Oncology), Karmanos Cancer Institute, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0218492316683757DOI Listing
January 2017

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 12 31;34(34):4079-4085. Epub 2016 Oct 31.

Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Alice T. Shaw, Massachusetts General Hospital; Leena Gandhi, Dana-Farber Cancer Institute, Boston, MA; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Mark A. Socinski, University of Pittsburgh, Pittsburgh, PA; D. Ross Camidge, University of Colorado Cancer Center, Denver, CO; Alberto Chiappori, Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Sai-Hong Ignatius Ou, University of California at Irvine, Orange, CA; Luigi De Petris, Karolinska Institutet, Stockholm, Sweden; Dong-Wan Kim, Seoul National University Hospital, Seoul; Ji-Youn Han, Lung Cancer Centre, National Cancer Centre, Goyang, South Korea; Denis L. Moro-Sibilot, Service de Pneumologie; Michael Duruisseaux, Centre Hospitalier Universitaire de Grenoble, Grenoble; Eric Dansin, Centre Oscar Lambret, Lille, France; Lucio Crino, Santa Maria della Misericordia Hospital, Perugia; Tommaso De Pas, European Institute of Oncology, Milan, Italy; Antje Tessmer, Evangelische Lungenklinik Berlin, Berlin, Germany; James Chih-Hsin Yang, Graduate Institute of Oncology and Cancer Research Centre, National Taiwan University, Taipei, Taiwan; and Walter Bordogna, Sophie Golding, and Ali Zeaiter, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.4639DOI Listing
December 2016

Drug selection for anaplastic lymphoma kinase-positive non-small-cell lung cancer.

Lancet Oncol 2016 12 8;17(12):1627-1628. Epub 2016 Nov 8.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30567-8DOI Listing
December 2016

Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer.

Semin Respir Crit Care Med 2016 10 12;37(5):760-770. Epub 2016 Oct 12.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0036-1592337DOI Listing
October 2016

Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2017 01 22;18(1):e21-e26. Epub 2016 Jul 22.

Division of Radiation Oncology, Department of Oncology, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576136PMC
January 2017

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.

J Clin Oncol 2016 08 20;34(24):2874-80. Epub 2016 Jun 20.

Louis A. Penner, Terrance L. Albrecht, Tanina Foster, Felicity W.K. Harper, Lauren M. Hamel, Anthony F. Shields, Shirish Gadgeel, Michael S. Simon, and Susan Eggly, Wayne State University; Robert Chapman, Henry Ford Health Care System, Detroit; Richard Gonzalez and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI; John F. Dovidio, Yale University, New Haven, CT; and Nao Hagiwara, Virginia Commonwealth University, Richmond, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012663PMC
August 2016

Personalized Therapy of Non-small Cell Lung Cancer (NSCLC).

Adv Exp Med Biol 2016 ;890:203-22

Karmanos Cancer Institute, Wayne State University, 4100 John R, 4, HWCRC, Detroit, MI, 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-24932-2_11DOI Listing
May 2016

Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.

Front Oncol 2015 21;5:238. Epub 2015 Oct 21.

Department of Immunology and Microbiology, Karmanos Cancer Institute, Wayne State University School of Medicine , Detroit, MI , USA ; Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine , Detroit, MI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617099PMC
November 2015

Cyclooxygenase 2 inhibition in patients with non-small cell lung cancer: Is this still a valid target for therapy?

Cancer 2015 Sep 29;121(18):3197-200. Epub 2015 May 29.

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29479DOI Listing
September 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.

J Thorac Oncol 2014 Nov;9(11):1704-8

*Cedars-Sinai Medical Center, Los Angeles, California; †The Lung Cancer Group, The Christie and University Hospital of South Manchester, Manchester, United Kingdom; ‡Memorial Cancer Centre of Oncology and Institute Department of Lung Cancer and Chest Tumours, Warsaw, Poland; §Poznań University of Medical Sciences, Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznań, Poland; ‖Karmanos Cancer Center, Detroit, Michigan; ¶Lung Cancer Unit, IRCCS AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; #Gemeinschaftspraxis für Haematologie, Onkologie und Palliativmedizin, Münster, Germany; **Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida; ††St. Vincentius-Kliniken gAG - Med. Klinik Abt. 2, Karlsruhe, Germany; ‡‡Sheffield Experimental Cancer Medicine Centre, Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom; §§Internal Medicine, Karmanos Cancer Institute, Detroit, Michigan; ‖‖Eli Lilly and Company, Windlesham, United Kingdom; ¶¶Eli Lilly and Company, Basingstoke, Hampshire, United Kingdom; ##Eli Lilly and Company, Indianapolis, Indiana; and ***Department of Oncology, University of Oxford, Cancer and Haematology Center, Churchill Hospital, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340255PMC
November 2014

Racial diversity of actionable mutations in non-small cell lung cancer.

J Thorac Oncol 2015 Feb;10(2):250-5

Barbara Ann Karmanos Cancer Institute and Department of Oncology, Wayne State University, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305026PMC
February 2015

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer.

Lung Cancer (Auckl) 2014 6;5:35-42. Epub 2014 Aug 6.

Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S50414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217506PMC
August 2014

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.

J Clin Oncol 2014 Aug 7;32(23):2463-70. Epub 2014 Jul 7.

Jeffrey W. Allen, University of Tennessee Health Science Center, Memphis, TN; James Moon, Mary Redman, Southwest Oncology Group Statistical Center, Seattle, WA; Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Karen Kelly, Phillip C. Mack, David R. Gandara, University of California Davis Cancer Center, Sacramento, CA; Hanna M. Saba, Central Illinois CCOP/Cancer Care Specialists of Central Illinois, Effingham, IL; Mohamed K. Mohamed, Moses Cone Health System, Greensboro, NC; and Mohammad Jahanzeb, University of Miami, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121504PMC
August 2014

Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.

Transl Oncol 2014 May 23. Epub 2014 May 23.

Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2014.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145357PMC
May 2014

Prognostic and predictive markers for personalized adjuvant therapy for non-small-cell lung cancer patients.

Future Oncol 2013 Dec;9(12):1909-21

Department of Oncology, Wayne State University & Molecular Theapeutics Program, Karmanos Cancer Institute, 4100 John R, Mailcode: HW02EA, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon.13.160
Publisher Site
http://dx.doi.org/10.2217/fon.13.160DOI Listing
December 2013

Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.

PLoS One 2013 8;8(11):e79820. Epub 2013 Nov 8.

Karmanos Cancer Institute & Department of Oncology, Wayne State University, Detroit, Michigan, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079820PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821849PMC
July 2014